Thermo Fisher Scientific (TMO) has issued $3.8 billion in senior unsecured notes across four tranches to fund a portion of its acquisition of Clario Holdings, Inc. The company expects net proceeds of approximately $3.76 billion. While the immediate use is for the acquisition, funds may temporarily be allocated to general corporate purposes or short-term investments, demonstrating Thermo Fisher’s strategy of using debt markets for strategic M&A and financial flexibility.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Thermo Fisher Issues $3.8 Billion Notes for Acquisition
Thermo Fisher Scientific (TMO) has issued $3.8 billion in senior unsecured notes across four tranches to fund a portion of its acquisition of Clario Holdings, Inc. The company expects net proceeds of approximately $3.76 billion. While the immediate use is for the acquisition, funds may temporarily be allocated to general corporate purposes or short-term investments, demonstrating Thermo Fisher’s strategy of using debt markets for strategic M&A and financial flexibility.